Adjuvant Gemcitabine Plus Docetaxel Followed by Doxorubicin Versus Observation for High-Grade Uterine Leiomyosarcoma: A Phase III NRG Oncology/Gynecologic Oncology Group Study
Publication year
2018Source
Journal of Clinical Oncology, 36, 33, (2018), pp. 3324-3330ISSN
Publication type
Article / Letter to editor

Display more detailsDisplay less details
Organization
Medical Oncology
IQ Healthcare
Journal title
Journal of Clinical Oncology
Volume
vol. 36
Issue
iss. 33
Page start
p. 3324
Page end
p. 3330
Subject
All institutes and research themes of the Radboud University Medical Center; Radboudumc 17: Women's cancers RIHS: Radboud Institute for Health SciencesThis item appears in the following Collection(s)
- Academic publications [202786]
- Faculty of Medical Sciences [80017]
Upload full text
Use your RU credentials (u/z-number and password) to log in with SURFconext to upload a file for processing by the repository team.